相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
Jiabo Li et al.
CANCER GENE THERAPY (2022)
Discovering dominant tumor immune archetypes in a pan-cancer census
Alexis J. Combes et al.
CELL (2022)
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
M. Palmeri et al.
ESMO OPEN (2022)
Targeted therapies for cancer
Zhijun Zhou et al.
BMC MEDICINE (2022)
The translational challenges of precision oncology
Oriol Pich et al.
CANCER CELL (2022)
Pan-cancer analysis of prognostic metastatic phenotypes
Nicholas G. Zaorsky et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Multiple roles for basement membrane proteins in cancer progression and EMT
Samarpita Banerjee et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2022)
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Yoshikatsu Kanai
PHARMACOLOGY & THERAPEUTICS (2022)
Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function
Gokcen Eraslan et al.
SCIENCE (2022)
Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis
Jaffer A. Ajani et al.
EUROPEAN JOURNAL OF CANCER (2022)
A transmembrane protein family gene signature for overall survival prediction in osteosarcoma
Yuehui Du et al.
FRONTIERS IN GENETICS (2022)
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
Yingkun Xu et al.
BIOMED RESEARCH INTERNATIONAL (2022)
TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-? to Mediate EMT in Triple-Negative Breast Cancer
Jiaci Tong et al.
JOURNAL OF CANCER (2022)
DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS
Giulia Biffi et al.
PHYSIOLOGICAL REVIEWS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Denis L. Jardim et al.
CANCER CELL (2021)
Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis
Yan Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients
Ye Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Current and future cancer staging after neoadjuvant treatment for solid tumors
David R. Byrd et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway
Yue Fu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process
Marx Sebastien et al.
SEMINARS IN CANCER BIOLOGY (2020)
The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome
Elisa D'Arcangelo et al.
BRITISH JOURNAL OF CANCER (2020)
Origin and functional heterogeneity of fibroblasts
Valerie S. LeBleu et al.
FASEB JOURNAL (2020)
SnapShot: Cancer-Associated Fibroblasts
Danielle Park et al.
CELL (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Microsatellite instability in cancer: a novel landscape for diagnostic and therapeutic approach
Hiroyuki Yamamoto et al.
ARCHIVES OF TOXICOLOGY (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
Cell type-specific genetic regulation of gene expression across human tissues
Sarah Kim-Hellmuth et al.
SCIENCE (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
The Role of EMC during Membrane Protein Biogensis
Patrick J. Chitwood et al.
TRENDS IN CELL BIOLOGY (2019)
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
A. B. Schrock et al.
ANNALS OF ONCOLOGY (2019)
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
J. L. Hu et al.
MOLECULAR CANCER (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
TMEM Proteins in Cancer: A Review
Kathleen Schmit et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J. M. Pitt et al.
ANNALS OF ONCOLOGY (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Overexpression of TMEM158 contributes to ovarian carcinogenesis
Zhongping Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Disease-free survival as an end-point in the treatment of solid tumours - Perspectives from clinical trials and clinical practice
Andrew G. Robinson et al.
EUROPEAN JOURNAL OF CANCER (2014)
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas
Larsson Omberg et al.
NATURE GENETICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells
Ahmed El Sayed Mohammed et al.
EXPERIMENTAL LUNG RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Overcoming the challenges of membrane protein crystallography
Elisabeth P. Carpenter et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
Target genes of the WNT/β-catenin pathway in Wilms tumors
B Zirn et al.
GENES CHROMOSOMES & CANCER (2006)
RIS1, a gene with trinucleotide repeats, is a target in the mutator pathway of colorectal carcinogenesis
Daniel Iglesias et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas
J Silva et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
A twist for survival and cancer progression
A Puisieux et al.
BRITISH JOURNAL OF CANCER (2006)
Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence
M Barradas et al.
EXPERIMENTAL CELL RESEARCH (2002)